Engaged Capital Makes Headlines Following Agreement with HeartWare and HeartWare’s Termination of Valtech Acquisition

Firm News

The Boston Business Journal, StreetInsider, Reuters and other media publications have reported on the agreement reached between Olshan client Engaged Capital, LLC and HeartWare International, Inc. following HeartWare’s termination of its proposed acquisition of Valtech Cardio. Engaged Capital had previously launched a proxy campaign in opposition to HeartWare’s acquisition of Valtech and nominated director candidates for election to HeartWare’s Board of Directors. Pursuant to the agreement, Engaged Capital and HeartWare will jointly select an additional independent director to be appointed to HeartWare’s Board and HeartWare agreed to form a business strategy committee. Steve Wolosky, Meagan Reda and Ryan P. Nebel represented Engaged Capital in connection with its investment in HeartWare.  

Media Contact

Marketing Contact
Mizi Mehaj
Marketing & Administrative Manager
mmehaj@olshanlaw.com
212.451.2319


Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.